Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1334717

GTEX

d3ba8679-1a2a-5623-bf38-dd04c58574f0

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PANCREAS_BETA_CELLS+0.314
  • HEDGEHOG_SIGNALING+0.208
  • SPERMATOGENESIS+0.188
  • KRAS_SIGNALING_DN+0.173
  • PEROXISOME-0.078
  • APICAL_SURFACE-0.079
  • WNT_BETA_CATENIN_SIGNALING-0.117
  • BILE_ACID_METABOLISM-0.128
  • APICAL_JUNCTION-0.152
  • MYOGENESIS-0.160

Top 10 suppressed

  • MYC_TARGETS_V1-0.520
  • G2M_CHECKPOINT-0.480
  • IL6_JAK_STAT3_SIGNALING-0.471
  • E2F_TARGETS-0.461
  • TNFA_SIGNALING_VIA_NFKB-0.459
  • ANGIOGENESIS-0.448
  • MYC_TARGETS_V2-0.400
  • ANDROGEN_RESPONSE-0.398
  • TGF_BETA_SIGNALING-0.394
  • COMPLEMENT-0.392

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

8 twins match this tumor's tissue · 2 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1321183
brain-umap@2
GTEX0.968
2SRR661179
brain-umap@2
GTEX0.967
3SRR1478032
brain-umap@2
GTEX0.966
4SRR1443713
brain-umap@2
GTEX0.961
5SRR4195666
colon-landscapes@1
0.951
6MNG700
mng-umap@100
0.945
7BS_3P20Q2C3
brain-umap@2
low-grade glioma0.940
8BS_90B22NGP
brain-umap@2
ATRT0.939
9SRR1311182
brain-umap@2
GTEX0.939
10SRR1797231
lung-landscapes@6
cohortSC0.937

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PANCREAS_BETA_CELLS0.314Cobimetinib— uncovered
HEDGEHOG_SIGNALING0.208Inavolisib— uncovered
SPERMATOGENESIS0.188Inavolisib— uncovered
KRAS_SIGNALING_DN0.173Remibrutinib— uncovered